InvestorsHub Logo
Followers 8
Posts 628
Boards Moderated 0
Alias Born 05/26/2021

Re: powerbattles post# 12381

Friday, 05/13/2022 2:43:55 PM

Friday, May 13, 2022 2:43:55 PM

Post# of 13742
Share price currently is indeed frustrating..
however, while extremely frustrating, the past year had many bumps and delays that were unfortunate and unforeseeable….
The run up to 0.20 was on speculation of fda. … as a share holder during that run it was great to witness its potential with news … unfortunately, the fda while accepting all of the data on escozine to that point that they asked of qnta then asked for additional things that prior to Covid vaccines the fda didn’t require … the new tests created huge delays … the RS debacle was crippling as folks panicked based on fears of experienced RS from OTHER companies they assumed similar could happen here…. Packaging delay from gloabal shipping issues slowed the roll out of imunapen and then the high profile NFL & dicks sporting goods events all were canceled due to the national fear of being accused of super spreader events .. mean while all these things discouraged investors…. However, the very noteworthy thing is the company managed to keep moving forward … and in spite of then another blow - the sec investigation… qnta continues to persevere and garner traction on the escozine track…. The last nights cc was incredibly informative and straight forward explaining much in regard to all the questions and concerns on iHub
I’m going to re listen to the cc when I have time to sit with paper and pen to take notes. For those with super busy schedules I suggest playing it while you drive or listen a few times while doing other things… that way if your casually listening you’ll pick up on key things ..
personally I found the information shared to be relevant and forthcoming

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.